Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Receivables (2016 - 2025)

Historic Receivables for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $8.3 million.

  • Rockwell Medical's Receivables fell 627.95% to $8.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year decrease of 627.95%. This contributed to the annual value of $8.3 million for FY2024, which is 2394.28% down from last year.
  • Rockwell Medical's Receivables amounted to $8.3 million in Q3 2025, which was down 627.95% from $8.1 million recorded in Q2 2025.
  • Rockwell Medical's Receivables' 5-year high stood at $16.2 million during Q2 2022, with a 5-year trough of $5.4 million in Q2 2023.
  • For the 5-year period, Rockwell Medical's Receivables averaged around $10.3 million, with its median value being $10.7 million (2021).
  • Per our database at Business Quant, Rockwell Medical's Receivables crashed by 6655.75% in 2023 and then soared by 10033.27% in 2024.
  • Quarter analysis of 5 years shows Rockwell Medical's Receivables stood at $11.8 million in 2021, then crashed by 47.07% to $6.3 million in 2022, then soared by 74.17% to $10.9 million in 2023, then dropped by 23.94% to $8.3 million in 2024, then increased by 0.45% to $8.3 million in 2025.
  • Its Receivables stands at $8.3 million for Q3 2025, versus $8.1 million for Q2 2025 and $9.7 million for Q1 2025.